Global burden of blood-pressure-related disease, 2001

CMM Lawes, S Vander Hoorn, A Rodgers - The Lancet, 2008 - thelancet.com
CMM Lawes, S Vander Hoorn, A Rodgers
The Lancet, 2008thelancet.com
Background Few studies have assessed the extent and distribution of the blood-pressure
burden worldwide. The aim of this study was to quantify the global burden of disease related
to high blood pressure. Methods Worldwide burden of disease attributable to high blood
pressure (≥ 115 mm Hg systolic) was estimated for groups according to age (≥ 30 years),
sex, and World Bank region in the year 2001. Population impact fractions were calculated
with data for mean systolic blood pressure, burden of deaths and disability-adjusted life …
Background
Few studies have assessed the extent and distribution of the blood-pressure burden worldwide. The aim of this study was to quantify the global burden of disease related to high blood pressure.
Methods
Worldwide burden of disease attributable to high blood pressure (≥115 mm Hg systolic) was estimated for groups according to age (≥30 years), sex, and World Bank region in the year 2001. Population impact fractions were calculated with data for mean systolic blood pressure, burden of deaths and disability-adjusted life years (DALYs), and relative risk corrected for regression dilution bias.
Findings
Worldwide, 7·6 million premature deaths (about 13·5% of the global total) and 92 million DALYs (6·0% of the global total) were attributed to high blood pressure. About 54% of stroke and 47% of ischaemic heart disease worldwide were attributable to high blood pressure. About half this burden was in people with hypertension; the remainder was in those with lesser degrees of high blood pressure. Overall, about 80% of the attributable burden occurred in low-income and middle-income economies, and over half occurred in people aged 45–69 years.
Interpretation
Most of the disease burden caused by high blood pressure is borne by low-income and middle-income countries, by people in middle age, and by people with prehypertension. Prevention and treatment strategies restricted to individuals with hypertension will miss much blood-pressure-related disease.
thelancet.com